Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Azilsartan manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

azilsartan

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

Manufacturer usually replies in 29 days

azilsartan

Tablets 20 mg, 40 mg, 80 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21769
A pharmaceutical manufacturer producing a wide range of oral solids, liquids and dry-syrup pharmaceutical products designed for broad therapeutic use and export to international markets. The company operates WHO-GMP and EU-GMP certified facilities and complies with multiple global regulatory standards, emphasising research and development alongside manufacturing to support quality, safety and reliability in its pharmaceutical products.

Manufacturer usually replies in 45 days

azilsartan

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212
The company is a specialty-focused pharmaceutical firm with a vision to become a leading Indian multinational, offering high-quality medicines globally. Established in 2011, the company quickly grew to become a significant player in the cardiovascular and anti-diabetic therapy areas, achieving a milestone of Rs 200 crore within ten years. The company's mission centers on ethical processes, employee-friendly initiatives, and a commitment to quality. Aiming to reach a turnover of 1000 crore by 2030, the company values transparency, ethical behavior, and inclusivity, fostering a culture of debate and understanding to drive growth and success.

Manufacturer usually replies in 38 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.